HITh lab InsermU1176
@hithlabinserm1176.bsky.social
In search of a #FVIII equivalence for non-factor therapies, we applied in vivo bleeding models 🩸 🐁 . This study suggests that a single FVIII equivalence is unlikely for #emicizumab #SIAmarstacimab and similar molecules.
April 5, 2025 at 10:02 AM
In search of a #FVIII equivalence for non-factor therapies, we applied in vivo bleeding models 🩸 🐁 . This study suggests that a single FVIII equivalence is unlikely for #emicizumab #SIAmarstacimab and similar molecules.